1Department of Pediatric Endocrinology, Ankara Child Diseases, Hematology and Oncology Training Hospital, Ankara, Turkey
2Department of Neonatology, Ankara Child Diseases, Hematology and Oncology Training Hospital, Ankara, Turkey
3Department of Pediatric Cardiology, Ankara Child Diseases, Hematology and Oncology Training Hospital, Ankara, Turkey
4Department of Pediatrics, Ankara Child Diseases, Hematology and Oncology Training Hospital, Ankara, Turkey
Corresponding author: Fatma Demirel, Department of Pediatric Endocrinology, Ankara Child Diseases, Hematology and Oncology Training Hospital, Ankara, Turkey Phone: +90 312 596 9666, Fax: +90 312 347 23 30
Citation Information: Journal of Pediatric Endocrinology and Metabolism. Volume 24, Issue 7-8, Pages 603–605, ISSN (Online) 2191-0251, ISSN (Print) 0334-018X, DOI: 10.1515/jpem.2011.238, August 2011
Abstract
Diazoxide is the main therapeutic agent for persistent hyperinsulinemic hypoglycemia. Generally, it is tolerated well, but rarely it can cause severe life-threatening complications. We report a neonate who was treated with diazoxide for hyperinsulinemic hypoglycemia. On the 6th day of the treatment we observed sepsis-mimicking symptoms, mild pulmonary hypertension, and re-opening of the ductus arteriosus. All these findings resolved dramatically shortly after discontinuation of treatment. To our knowledge, this is the first reported case of re-opening of the ductus arteriosus due to diazoxide toxicity.
Comments (0)